Capital Advisors, Ltd. LLC Neogenomics Inc Transaction History

Capital Advisors, Ltd. LLC

  • $806 Million
  • Q3 2024

A detailed history of Capital Advisors, Ltd. LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 37 shares of NEO stock, worth $549. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 37 -0.0%
Holding current value
$549
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$6.45 - $12.07 $1,257 - $2,353
-195 Reduced 84.05%
37 $0
Q2 2022

Aug 05, 2022
BUY
$7.06 - $13.97 $1,637 - $3,241
232 New
232 $2,000

Others Institutions Holding NEO

# of Institutions
292
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.87B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email